{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:07:35Z","timestamp":1770822455340,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Severe anaemia, with haemoglobin (Hb) levels \u22643\u2003g\u2003dL<jats:sup>\u22121<\/jats:sup>, is associated with mortality rates of 50\u201395%. Although accepted transfusion targets have been debated in the literature (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b1\">Carson <jats:italic>et al<\/jats:italic>., 2002<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b2\">Practice guidelines for blood component therapy. 1996<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b3\">Consensus Conference. 1988<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b4\">Hebert <jats:italic>et al<\/jats:italic>., 1999<\/jats:ext-link>), few would argue the risks associated with Hb levels less than 5\u2003g\u2003dL<jats:sup>\u22121<\/jats:sup> in critically ill patients. In patients who are unable to receive red blood cell transfusions, the utility of Hb solutions is an attractive solution. We describe a Jehovah's Witness patient who exemplifies the marked physiologic derangements of severe anaemia and subsequent clinical resolution with large volume polymerized human Hb transfusion. The Hb\u2010based oxygen carrier, PolyHeme\u00ae, provided adequate oxygen transport, acting as a bridge until endogenous production could compensate for red cell loss. Practicing physicians need to be aware of current therapeutic options for use in these complicated patients.<\/jats:p>","DOI":"10.1111\/j.0958-7578.2004.00502.x","type":"journal-article","created":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T16:04:40Z","timestamp":1086105880000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae"],"prefix":"10.1111","volume":"14","author":[{"given":"C. C.","family":"Cothren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Haenel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Ciesla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200115040-00009"},{"key":"e_1_2_4_3_1","first-page":"202","article-title":"Use of polymerized hemoglobin blood substitute instead of stored blood prevents endothelial cell activation","volume":"50","author":"Aiboshi J.","year":"1999","journal-title":"Surgery Forum"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70169-6"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200103000-00005"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X9101900419"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00123.x"},{"key":"e_1_2_4_8_1","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1001\/jama.1988.03410180108040","article-title":"Perioperative red blood cell transfusion","volume":"260","author":"Consensus Conference","year":"1988","journal-title":"JAMA: Journal of the American Medical Association"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.22.2827"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199911000-00004"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200204043461420"},{"key":"e_1_2_4_12_1","first-page":"93","article-title":"Induced hypotensive anesthesia for total hip replacement","volume":"101","author":"Davis N.J.","year":"1974","journal-title":"Clinical Orthopaedics"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198701083160203"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199802000-00023"},{"key":"e_1_2_4_15_1","first-page":"171","article-title":"The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell Volume expansion in autologous blood donors for elective orthopedic operation","volume":"179","author":"Goodnough L.T.","year":"1994","journal-title":"Journal of the American College of Surgeons"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(98)00095-7"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(02)01335-2"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199708000-00019"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900183"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199004000-00003"},{"key":"e_1_2_4_21_1","first-page":"60S","article-title":"Clinical experience with human polymerized hemoglobin","volume":"33","author":"Gould S.A.","year":"1993","journal-title":"Transfusion"},{"key":"e_1_2_4_22_1","first-page":"696","article-title":"Letter to the editor","volume":"347","author":"Hardy J.F.","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400601"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1987.tb02943.x"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200301000-00016"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200103000-00008"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(98)00275-X"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199011000-00016"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00184.x"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(91)90862-K"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198807000-00022"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198207000-00011"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004040050010"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-12-1042"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33193142311.x"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006013422204"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-198668030-00006"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/14017439009098063"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-7-552_1"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199603000-00032"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36196190512.x"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199808000-00014"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-198528010-00003"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/64.5.646"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200013010-00006"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0958-7578.2004.00502.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0958-7578.2004.00502.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:34:26Z","timestamp":1696937666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0958-7578.2004.00502.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.0958-7578.2004.00502.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0958-7578.2004.00502.x","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"2004-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}